These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12190888)
1. Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. Haustein KO; Krause J; Haustein H; Rasmussen T; Cort N J Intern Med; 2002 Aug; 252(2):130-9. PubMed ID: 12190888 [TBL] [Abstract][Full Text] [Related]
2. Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT). Haustein KO; Krause J; Haustein H; Rasmussen T; Cort N Int J Clin Pharmacol Ther; 2004 Feb; 42(2):83-92. PubMed ID: 15180168 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males. Haustein KO; Krause J; Haustein H; Rasmussen T; Cort N Nicotine Tob Res; 2003 Apr; 5(2):195-203. PubMed ID: 12745492 [TBL] [Abstract][Full Text] [Related]
4. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial. Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210 [TBL] [Abstract][Full Text] [Related]
5. Effects of high dose transdermal nicotine replacement in cigarette smokers. Hatsukami D; Mooney M; Murphy S; LeSage M; Babb D; Hecht S Pharmacol Biochem Behav; 2007 Jan; 86(1):132-9. PubMed ID: 17267026 [TBL] [Abstract][Full Text] [Related]
6. Effects of smoking cessation and reduction in asthmatics. Tønnesen P; Pisinger C; Hvidberg S; Wennike P; Bremann L; Westin A; Thomsen C; Nilsson F Nicotine Tob Res; 2005 Feb; 7(1):139-48. PubMed ID: 15804686 [TBL] [Abstract][Full Text] [Related]
7. Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving. Selby P; Andriash K; Zawertailo L; Persad D; Zack M; Busto UE J Clin Psychopharmacol; 2013 Oct; 33(5):667-74. PubMed ID: 23963055 [TBL] [Abstract][Full Text] [Related]
8. [Smoking reduction and temporary abstinence: new approaches for smoking cessation]. Le Houezec J; Säwe U J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435 [TBL] [Abstract][Full Text] [Related]
9. Nurse-conducted smoking cessation in patients with COPD using nicotine sublingual tablets and behavioral support. Tønnesen P; Mikkelsen K; Bremann L Chest; 2006 Aug; 130(2):334-42. PubMed ID: 16899830 [TBL] [Abstract][Full Text] [Related]
10. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up. Benowitz NL; Nardone N; Dains KM; Hall SM; Stewart S; Dempsey D; Jacob P Addiction; 2015 Oct; 110(10):1667-75. PubMed ID: 26198394 [TBL] [Abstract][Full Text] [Related]
11. Interventions to reduce harm from continued tobacco use. Stead LF; Lancaster T Cochrane Database Syst Rev; 2007 Jul; (3):CD005231. PubMed ID: 17636791 [TBL] [Abstract][Full Text] [Related]
12. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers. Sun HQ; Guo S; Chen DF; Jiang ZN; Liu Y; Di XL; Yang FD; Zhang XY; Kosten TR; Lu L Am J Drug Alcohol Abuse; 2009; 35(3):183-8. PubMed ID: 19462302 [TBL] [Abstract][Full Text] [Related]
13. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers. Ferguson SG; Gitchell JG; Shiffman S; Sembower MA Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485 [TBL] [Abstract][Full Text] [Related]
14. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol. Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841 [TBL] [Abstract][Full Text] [Related]
16. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. Hurt RD; Croghan GA; Beede SD; Wolter TD; Croghan IT; Patten CA Arch Pediatr Adolesc Med; 2000 Jan; 154(1):31-7. PubMed ID: 10632247 [TBL] [Abstract][Full Text] [Related]
17. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Becker KM; Rose JE; Albino AP Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723 [TBL] [Abstract][Full Text] [Related]
19. Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching. Hatsukami DK; Severson H; Anderson A; Vogel RI; Jensen J; Broadbent B; Murphy SE; Carmella S; Hecht SS Tob Control; 2016 May; 25(3):267-74. PubMed ID: 25991608 [TBL] [Abstract][Full Text] [Related]
20. Varying nicotine patch dose and type of smoking cessation counseling. Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]